Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of genes. It is primarily involved in the segments of the pharmaceutical, biotechnology, and other related markets that address gene control and ... Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of genes. It is primarily involved in the segments of the pharmaceutical, biotechnology, and other related markets that address gene control and cancer. The Company operates only in the United States. Mehr anzeigen
Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced that it will...
Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced that it will...
-- Pivotal Complete Response (CR) Data from SELECT-MDS-1 Phase 3 Trial Expected by Mid-4Q24 -- -- Additional Data from SELECT-AML-1 Phase 2 Trial Expected in September 2024-- -- Management to...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.39 | 24.8407643312 | 1.57 | 2.13 | 1.55 | 774252 | 1.89290072 | CS |
| 4 | 0.25 | 14.6198830409 | 1.71 | 2.13 | 1.43 | 315058 | 1.78980166 | CS |
| 12 | -3.79 | -65.9130434783 | 5.75 | 6.9275 | 1.43 | 305656 | 2.68851554 | CS |
| 26 | -4.05 | -67.387687188 | 6.01 | 6.9275 | 1.43 | 224279 | 3.6896022 | CS |
| 52 | -1.92 | -49.4845360825 | 3.88 | 8.17 | 1.43 | 212776 | 4.57461698 | CS |
| 156 | -2.93 | -59.918200409 | 4.89 | 8.17 | 0.65 | 377652 | 2.36416889 | CS |
| 260 | -9.48 | -82.8671328671 | 11.44 | 15.6499 | 0.65 | 461795 | 5.14793835 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
